Medicine and Dentistry
Adenoviridae
9%
Adverse Event
25%
Apoplexy
9%
Arm
15%
Atrial Septal Defect
8%
Biological Marker
12%
Biopsy
16%
Bleeding
22%
Body Mass Index
8%
Bone Tissue
8%
Breast Cancer
10%
Brugada Syndrome
11%
Cancer
10%
Cancer Cell
26%
Cancer Surgery
8%
Carcinoma
7%
Chemoradiotherapy
14%
Chondrocyte
8%
Chronic Kidney Disease
10%
Cisplatin
10%
Clinical Trial
12%
Cohort Analysis
13%
Combination Therapy
9%
Computer Assisted Tomography
43%
COVID-19
8%
Cross Sectional Study
12%
Dentin
11%
Diabetes Mellitus
9%
Diagnosis
22%
Disease
47%
Edentulism
10%
Elderly Patient
10%
Endoscopic Submucosal Dissection
15%
Endoscopic Ultrasound
8%
Epidermal Growth Factor Receptor
16%
Epileptic Absence
9%
Esophageal Cancer
11%
Fibroblast
10%
Gene Expression
10%
Hazard Ratio
12%
Heart Failure
10%
Hepatocellular Carcinoma
20%
Immunoglobulin G4
8%
Immunohistochemistry
10%
In Vitro
20%
Infection
18%
Injury
16%
Knee
14%
Liver Transplantation
7%
Logistic Regression Analysis
8%
Lower Jaw
9%
Lung Cancer
33%
Lung Metastasis
8%
Lung Transplantation
24%
Lymph Node
9%
Lymph Node Metastasis
13%
Magnetic Resonance Imaging
31%
Malignant Neoplasm
47%
MALT Lymphoma
8%
Metastatic Carcinoma
19%
Mouth Squamous Cell Carcinoma
11%
Multivariate Analysis
13%
Neoplasm
100%
Non Small Cell Lung Cancer
33%
Observational Study
19%
Odds Ratio
20%
Optical Coherence Tomography
17%
Osteosarcoma
9%
Overall Survival
28%
Pancreas Cancer
10%
Pediatrics
11%
Periodontitis
10%
Postoperative Complication
8%
Prevalence
13%
Prognostic Factor
14%
Programmed Cell Death
11%
Progression Free Survival
9%
Prospective Cohort Study
9%
Pulmonary Hypertension
10%
Quality of Life
10%
Radiation Therapy
17%
Radiofrequency Ablation
18%
Randomized Controlled Trial
9%
Recurrent Disease
34%
Resuscitation
8%
Retrospective Cohort Study
8%
Retrospective Study
22%
Rheumatoid Arthritis
8%
Salicylic Acid
9%
Soft Tissue Sarcoma
12%
Squamous Cell Carcinoma
13%
Stomach Cancer
18%
Surgery
44%
Surgical Technique
8%
Survival Rate
20%
Suture Material
9%
Symptom
21%
Telomerase
11%
Tumor Cell
10%
Tumor Progression
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
6%
Adenoviridae
12%
Adenovirus Vector
6%
Adverse Event
19%
Alzheimer's Disease
9%
Antioxidant
13%
Asthma
7%
Atherosclerosis
6%
Biological Marker
13%
Bleeding
6%
Breast Cancer
10%
Brugada Syndrome
7%
Calcium Ion
7%
Carcinogenesis
6%
Cardiovascular Disease
8%
Chemoradiation Therapy
11%
Chemotherapy
29%
Chronic Kidney Failure
9%
Cisplatin
12%
Clinical Trial
13%
Cohort Study
11%
Combination Therapy
14%
Coronary Artery Disease
6%
Cross-Sectional Study
7%
Cytokine
15%
Diabetes Mellitus
8%
Disease
42%
Dopamine Receptor Stimulating Agent
7%
Doxorubicin
10%
Edaravone
6%
Epidermal Growth Factor Receptor
26%
Epidermal Growth Factor Receptor Kinase Inhibitor
6%
Esophagus Cancer
8%
Fibrosis
6%
Fluorine 18
6%
Gamma Urogastrone
6%
Gefitinib
6%
Glycoprotein
7%
Heart Failure
8%
Hepatitis C Virus
9%
Histamine
10%
Histidine
7%
Immune Checkpoint Inhibitor
6%
Infection
16%
Inflammation
22%
Injury
8%
Intercellular Adhesion Molecule 1
7%
Interferon
8%
Interleukin 18
7%
Interleukin 6
7%
Ischemia
7%
Lipopolysaccharide
8%
Liver Cell Carcinoma
23%
Lung Cancer
31%
Malignant Neoplasm
58%
Metastasis
6%
microRNA
6%
Monoclonal Antibody
6%
Mouse
72%
Mouse Model
19%
Neoplasm
66%
Neuroprotective Agent
8%
Non Small Cell Lung Cancer
37%
Nonalcoholic Fatty Liver
10%
Normal Human
9%
Observational Study
11%
Oncolytic Adenovirus
7%
Overall Survival
19%
Paclitaxel
7%
Pancreas Cancer
9%
Parkinson's Disease
9%
Periodontitis
11%
Pharmacokinetics
7%
Phosphotransferase
6%
Prevalence
13%
Progression Free Survival
10%
Protein P53
15%
Proteinase
7%
Pulmonary Hypertension
9%
Randomized Controlled Trial
7%
Reactive Oxygen Metabolite
7%
Receptor
14%
Receptor Agonist
7%
Recurrent Disease
15%
Remission
7%
Retinoid X Receptor
10%
Retrospective Study
8%
Rheumatoid Arthritis
6%
Squamous Cell Carcinoma
6%
Stomach Cancer
11%
Survival Rate
12%
Symptom
17%
Syndrome
7%
Telomerase
10%
Therapeutic Effect
8%
Tumor Growth
9%
Tumor Necrosis Factor
12%
Tumor Suppressor Protein
6%
Vasculotropin
6%
Virotherapy
6%
Keyphrases
Adenovirus
7%
Antitumor Effect
5%
Apoptosis
6%
Cancer Cells
6%
CCN2
5%
Cisplatin
6%
Clinical Outcomes
7%
Computed Tomography
5%
Confidence Interval
13%
EGFR mutation
6%
Gastric Cancer
5%
Gene Expression
5%
Hazard Ratio
6%
High Mobility Group Box 1 (HMGB1)
5%
Histamine
8%
Japan
28%
Japanese Patients
6%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
5%
Lung Cancer
8%
Lung Transplantation
8%
Medial Meniscus Posterior Root Tear
7%
Non-small Cell Lung Cancer (NSCLC)
15%
Odds Ratio
6%
Okayama
9%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
6%
Overall Survival
7%
Oxidative Stress
9%
Radiofrequency Ablation
6%
Risk Factors
7%
Telomerase
7%
Tumor
14%
Tumor Necrosis Factor-α
5%